Influenza, Human  >>  fingolimod  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fingolimod / Generic mfg.
NCT01199861 / 2010-019028-30: Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Completed
3
138
Canada, Europe, RoW
Fingolimod, FTY720, Placebo, Seasonal influenza vaccine, Agrippal (TM), Tetanus toxoid vaccine, Tetanol (TM)
Novartis
Relapsing Multiple Sclerosis
05/11
05/11

Download Options